|
US6207665B1
(en)
|
1997-06-12 |
2001-03-27 |
Schering Aktiengesellschaft |
Piperazine derivatives and their use as anti-inflammatory agents
|
|
JP2000273087A
(ja)
|
1999-03-24 |
2000-10-03 |
Mitsui Chemicals Inc |
非対称２−イミダゾリジノン類の製造方法
|
|
CA2470813A1
(en)
|
2001-12-20 |
2003-07-03 |
Bayer Healthcare Ag |
1,4-dihydro-1,4-diphenylpyridine derivatives
|
|
US7385076B2
(en)
|
2002-05-31 |
2008-06-10 |
Sun Pharmaceutical Industries Limited |
Process for the preparation of phenylcarbamates
|
|
GB0219896D0
(en)
|
2002-08-27 |
2002-10-02 |
Bayer Ag |
Dihydropyridine derivatives
|
|
US7230017B2
(en)
|
2002-08-27 |
2007-06-12 |
Bayer Healthcare Ag |
Dihydropyridinone derivatives
|
|
BR0314186A
(pt)
|
2002-09-10 |
2005-08-09 |
Bayer Healthcare Ag |
Derivados de pirimidinona como agentes terapêuticos contra processos inflamatórios, isquêmicos e remodeladores, agudos e crÈnicos
|
|
CA2498052C
(en)
|
2002-09-10 |
2011-05-17 |
Bayer Healthcare Ag |
Heterocyclic derivatives
|
|
GB2392910A
(en)
|
2002-09-10 |
2004-03-17 |
Bayer Ag |
2-Oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors
|
|
SE0302324D0
(sv)
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
|
EP1723121B1
(en)
|
2004-02-26 |
2012-07-25 |
Bayer Pharma Aktiengesellschaft |
1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
|
|
CA2557272C
(en)
|
2004-02-26 |
2012-09-11 |
Bayer Healthcare Ag |
Heterocyclic derivatives
|
|
PL201306B1
(pl)
|
2004-07-28 |
2009-03-31 |
Politechnika Wroclawska |
Sposób wytwarzania N,N'-alkilidenobis(karbaminianów) dialkilowych
|
|
GB0502258D0
(en)
|
2005-02-03 |
2005-03-09 |
Argenta Discovery Ltd |
Compounds and their use
|
|
DE102005028845A1
(de)
|
2005-06-22 |
2006-12-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
|
|
GB0512940D0
(en)
|
2005-06-24 |
2005-08-03 |
Argenta Discovery Ltd |
Compounds and their use
|
|
BRPI0617513A2
(pt)
|
2005-10-20 |
2011-07-26 |
Sumitomo Chemical Co |
compostos de benzoilurÉia, processo para a produÇço e uso dos mesmos e mÉtodo para controlar pestes
|
|
WO2009013444A1
(en)
|
2007-07-25 |
2009-01-29 |
Argenta Discovery Limited |
Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
|
|
PT2024367E
(pt)
|
2006-05-04 |
2010-12-03 |
Pulmagen Therapeutics Inflammation Ltd |
Tetra-hidropirrolopirimidinadionas e a sua utilização a título de inibidores da elastase de neutrófilos humana
|
|
US8198288B2
(en)
|
2006-05-04 |
2012-06-12 |
Pulmagen Therapeutics (Inflammation) Limited |
Tetrahydropyrrolopyrimidinediones and their use in therapy
|
|
GB0610765D0
(en)
|
2006-05-31 |
2006-07-12 |
Proskelia Sas |
Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
|
|
DE102006031314A1
(de)
|
2006-07-01 |
2008-01-03 |
Bayer Healthcare Aktiengesellschaft |
Verwendung von 1,4-Diaryl-dihydropyrimidin-2-on-Derivaten zur Behandlung der pulmonalen arteriellen Hyptertonie
|
|
US20100010024A1
(en)
|
2006-07-01 |
2010-01-14 |
Bayer Healthcare Ag |
Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension
|
|
CN101225083A
(zh)
*
|
2007-01-16 |
2008-07-23 |
北京摩力克科技有限公司 |
四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
|
|
WO2009037413A1
(en)
|
2007-09-19 |
2009-03-26 |
Argenta Discovery Limited |
Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases
|
|
GB0721866D0
(en)
|
2007-11-07 |
2007-12-19 |
Argenta Discovery Ltd |
Pharmaceutical compounds having dual activities
|
|
WO2009060158A1
(en)
|
2007-11-07 |
2009-05-14 |
Argenta Discovery Limited |
4- (4-cyanophenyl) -1- (3-trifluoromethylphenyl) -3,4, 6, 7-tetrahydro-1h-pyrrolo [3, 4- d] pyrimidine-2, 5-dione derivatives and their use as human neutrophil elastase inhibitors
|
|
WO2009060206A1
(en)
|
2007-11-07 |
2009-05-14 |
Argenta Discovery Limited |
3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
|
|
DE102007061766A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
4-(4-Cyano-2-thioaryl)-dihydropyrimidinone und ihre Verwendung
|
|
DE102008022521A1
(de)
|
2008-05-07 |
2009-11-12 |
Bayer Schering Pharma Aktiengesellschaft |
1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung
|
|
DE102008052013A1
(de)
|
2008-10-17 |
2010-04-22 |
Bayer Schering Pharma Aktiengesellschaft |
4-(4-Cyano-2-thioaryl)-dihydropyrimidinone und ihre Verwendung
|
|
ATE548355T1
(de)
|
2007-12-20 |
2012-03-15 |
Bayer Pharma AG |
4- (4-cyano-2-thioaryl) -dihydropyrimidinone und ihre verwendung
|
|
DE102009004197A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung
|
|
DE102009016553A1
(de)
|
2009-04-06 |
2010-10-07 |
Bayer Schering Pharma Aktiengesellschaft |
Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung
|
|
US8865704B2
(en)
|
2009-10-07 |
2014-10-21 |
Siena Biotech S.P.A. |
Wnt pathway antagonists
|
|
MY160249A
(en)
|
2010-01-08 |
2017-02-28 |
Catabasis Pharmaceuticals Inc |
Fatty acid fumarate derivatives and their uses
|
|
WO2011094953A1
(en)
|
2010-02-08 |
2011-08-11 |
F. Hoffmann-La Roche Ag |
Compounds for the treatment and prevention of influenza
|
|
GB201004179D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
GB201004178D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
|
JP2013177318A
(ja)
|
2010-06-30 |
2013-09-09 |
Dainippon Sumitomo Pharma Co Ltd |
ジヒドロピリミジノン誘導体およびその医薬用途
|
|
US9040516B2
(en)
|
2011-08-01 |
2015-05-26 |
Sumitomo Dainippon Pharma Co., Ltd. |
Uracil derivative and use thereof for medical purposes
|
|
WO2013037809A1
(en)
|
2011-09-14 |
2013-03-21 |
Chiesi Farmaceutici S.P.A. |
Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors
|